At the very least, we have laid a pathway for the prolonged release of therapeutic GLP-1based anti-diabetic and anti-obesity treatments that could have beneficial impact on type 2 diabetes management and, perhaps, other conditions as well, Appel said in the same statement
Rare but serious concerns like pancreatitis risk exist with both GLP-1 and GIP agonists, so immediate medical attention is necessary if you experience severe abdominal pain
ARBs increase ACE2 (Zaheer et al., 2021) that degrades amyloid -peptide (A) in AD (Kehoe et al., 2016)
Approved by the FDA on 1 April 2026, it is the only oral GLP-1 receptor agonist that can be taken at any time of day without food or water restrictions, distinguishing it from oral Wegovy, which must be taken in the morning on an empty stomach
But Ozempic's use is limited to diabetes management, not weight loss
Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C